Microbiomes of Inflammatory Thoracic Aortic Aneurysms Due to Giant Cell Arteritis and Clinically Isolated Aortitis Differ From Those of Non-Inflammatory Aneurysms.
aneurysms
aorta
aortitis
clinically isolated aortitis
giant cell arteritis
microbiome
Journal
Pathogens & immunity
ISSN: 2469-2964
Titre abrégé: Pathog Immun
Pays: United States
ID NLM: 101683909
Informations de publication
Date de publication:
2019
2019
Historique:
received:
13
10
2018
accepted:
21
02
2019
entrez:
18
4
2019
pubmed:
18
4
2019
medline:
18
4
2019
Statut:
epublish
Résumé
We sought to characterize microbiomes of thoracic aortas from patients with non-infectious aortitis due to giant cell arteritis (GCA) and clinically isolated aortitis (CIA) and to compare them to non-inflammatory aorta aneurysm controls. We also compared microbiomes from concurrently processed and separately reported temporal arteries (TA) and aortas. From 220 prospectively enrolled patients undergoing surgery for thoracic aorta aneurysm, 49 were selected. Inflammatory and non-inflammatory cases were selected based on ability to match for age (+/-10 years), gender, and race. Biopsies were collected under aseptic conditions and snap-frozen. Taxonomic classification of bacterial sequences was performed to the genus level and relative abundances were calculated. Microbiome differential abundances were analyzed by principal coordinates analysis. Forty-nine patients with thoracic aortic aneurysms (12 CIA, 14 GCA, 23 non-inflammatory aneurysms) were enrolled. Alpha ( Thoracic aorta aneurysms, far from being sterile, contain unique microbiomes that differ from those found in temporal arteries. The aorta microbiomes are most similar between aneurysms that were associated with inflammation, GCA, and CIA, but differed from those associated with non-inflammatory etiologies. These findings are promising in that they indicate that microbes may play a role in the pathogenesis of aortitis-associated aneurysms or non-inflammatory aneurysms by promoting or protecting against inflammation. However, we cannot rule out that these changes are related to alterations in tissue substrate that favor secondary changes in microbial communities.
Identifiants
pubmed: 30993253
doi: 10.20411/pai.v4i1.269
pii: pai.v4i1.269
pmc: PMC6438704
doi:
Types de publication
Journal Article
Langues
eng
Pagination
105-123Déclaration de conflit d'intérêts
Gary S. Hoffman and Leonard H. Calabrese are associate editors for Pathogens and Immunity. They did not participate in any aspect of the review or editorial process of this submitted manuscript.
Références
Cardiovasc Pathol. 2017 Jul - Aug;29:23-32
pubmed: 28500877
Immunol Lett. 2014 Dec;162(2 Pt A):54-61
pubmed: 24972311
Immunology. 2017 Aug;151(4):363-374
pubmed: 28542929
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
Clin J Gastroenterol. 2018 Feb;11(1):1-10
pubmed: 29285689
Bioinformatics. 2011 Nov 1;27(21):2957-63
pubmed: 21903629
J Vasc Surg. 2006 Nov;44(5):1055-60
pubmed: 17098542
Sci Rep. 2015 May 19;5:9743
pubmed: 25988396
BMC Bioinformatics. 2004 Aug 19;5:113
pubmed: 15318951
Curr Opin Rheumatol. 2015 Jul;27(4):397-405
pubmed: 26002032
Oral Microbiol Immunol. 2001 Oct;16(5):316-8
pubmed: 11555310
Circulation. 2008 Jun 10;117(23):3039-51
pubmed: 18541754
Front Microbiol. 2018 Feb 23;9:249
pubmed: 29599752
Cardiovasc Pathol. 2015 Sep-Oct;24(5):267-78
pubmed: 26051917
Bioinformatics. 2010 Mar 15;26(6):715-21
pubmed: 20130030
Immunology. 2015 Feb;144(2):333-42
pubmed: 25179236
Am J Surg Pathol. 2006 Sep;30(9):1150-8
pubmed: 16931960
J Rheumatol. 1996 Jan;23(1):112-9
pubmed: 8838518
J Allergy Clin Immunol. 2007 Jun;119(6):1514-21
pubmed: 17481709
Microbiome. 2016 Nov 17;4(1):60
pubmed: 27855721
Clin Immunol. 2004 Jun;111(3):286-96
pubmed: 15183149
Appl Environ Microbiol. 2006 Jul;72(7):5069-72
pubmed: 16820507
Ann Intern Med. 1996 Dec 15;125(12):979-82
pubmed: 8967709
Ann Intern Med. 2016 Nov 1;165(9):ITC65-ITC80
pubmed: 27802475
Nat Rev Rheumatol. 2014 Aug;10(8):454-62
pubmed: 24934189
Arthritis Rheumatol. 2015 Jul;67(7):1913-21
pubmed: 25917817
Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):1405-11
pubmed: 12816879
Rheumatology (Oxford). 2009 May;48(5):475-82
pubmed: 19258377
Oncotarget. 2017 Oct 19;8(57):97273-97289
pubmed: 29228609
Pathog Immun. 2019 Feb 12;4(1):21-38
pubmed: 30993251
Arthritis Rheum. 2012 Jan;64(1):317-9
pubmed: 21953530
PeerJ. 2016 Oct 18;4:e2584
pubmed: 27781170
Arthritis Rheumatol. 2014 Jul;66(7):1939-44
pubmed: 24644069
J Oral Microbiol. 2017 Feb 8;9(1):1281562
pubmed: 28326156
Br J Dermatol. 2005 Jul;153(1):66-71
pubmed: 16029328
Arthritis Rheumatol. 2019 Dec;71(12):2112-2120
pubmed: 30730604
Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1061-7
pubmed: 10764674
Nat Biotechnol. 2013 Sep;31(9):814-21
pubmed: 23975157
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Arthritis Rheum. 2000 Jul;43(7):1543-51
pubmed: 10902759
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
Mol Biol Evol. 2009 Jul;26(7):1641-50
pubmed: 19377059